China’s People’s Liberation Army believes that biological weapons, not nuclear ones, are the key to global military dominance.
In our recent Gateway Pundit article, we described the 2005 and 2006 Chinese military publications of Colonel Ji-wei Guo, who advocated the use of biotechnology to develop new methods of waging war and recommended that military doctors take part in the creation of biological weapons.
In his 2008 book, “Biological Outlook on War and Foresight of Biotechnology Supremacy,” Colonel Guo elaborated on the application of biotechnology in bio-based warfare, which represents the “Third Leap” in military strategy:
“The third leap includes biotechnology and related sciences that develop and grow on the basis of information technology (including advanced computing and communication), nanoscience and other converging technologies, in which biotechnology and biomedical science (including genetic engineering) and cognitive science (including cognitive neuroscience) are comprehensively applied. It will bring enormous quantitative changes in the combat environment, combat methods, space-time relationship, military structure and function, and will eventually cause new qualitative changes, which will cause profound changes in modern military history. The change at the operational level brought by this military transformation is the expansion of the theory of power control with modern biotechnology as its main characteristic.”
READ ALSO: Unrestricted Warfare | ‘Lockdowns’ as a New Weapon in the Post-Nuclear Era
Colonel Guo’s comments do not merely represent the random reflections of a particular Chinese military officer, but were concepts adopted by the Chinese People’s Liberation Army and incorporated into its military doctrine.
In his 2012 article “Military Biotechnology Development and the Future of Bio-Based Warfare,” Major General Fu-Chu wrote:
“As an emerging technology, military biotechnology expands the concept of weaponry and equipment and becomes an important driving force behind the development of weaponry and equipment. In recent years, great progress has been made in many fields of military biotechnology, such as synthetic biology, brain-computer interface and brain control, as well as biological materials, bio-inspired machinery, biofuels, bioelectronics, bioinformatics and non-lethal weapons, giving rise to the birth of new operational concepts. In future wars, military biotechnology will promote bio-based weaponry and equipment, bio-based forces and bio-based combat style.”
Major General Fu-Chu Hi was president of the Academy of Military Medical Sciences, vice president of the Chinese Academy of Medical Sciences, alternate member of the 18th Central Committee of the Chinese Communist Party (CCP) and deputy director of the Science and Technology Committee affiliated with the Central Military Commission, which is the Chinese equivalent of the US Department of Defense’s Defense Advanced Research Projects Agency (DARPA).
Major General Chen Wei is currently director of the Institute of Biotechnology of the Academy of Military Medical Sciences and is believed to be the head of China’s biological warfare program.
She was put in charge of the “cleanup” operation in Wuhan after local authorities lost control of the COVID-19 outbreak. She also led China’s effort to create a COVID-19 vaccine.
In 2014, Major General Chen Wei co-authored the book “Biotechnology Development Yearbook, 2013,” in which she described the main biotechnological advances and their impact on military medical science.
The book contained 10 sections with 25 specific biotechnology topics, such as gene manipulation, synthetic biology, gene sequencing, biotherapeutics, biomaterials, bioinformatics, bioimaging, cloning and neurobiology.
In 2016, the Science and Technology Committee affiliated with the Central Military Commission launched the Thirteenth Five-Year Plan Military-Civil Fusion Science and Technology Program.
That program brought all Chinese universities, pharmaceutical companies and “civilian” research centers, such as the Wuhan Institute of Virology, into the People’s Liberation Army’s biotechnology warfare effort.
It is therefore not surprising that Major General Chen Wei’s predecessor as director of the Institute of Biotechnology and retired vice president of the Academy of Military Medical Sciences, Major General Pei-Tang Huang, became an independent director of Hualan Biological Bacterin Inc. on April 26, 2019.
Given the intensity of the military-civilian research fusion program, perhaps it is no coincidence that in the two or three months after Pei-Tang Huang’s appointment, the chief executives of twenty-three domestic and multinational pharmaceutical companies in China resigned or retired, including Sanofi, Roche, Bayer, Bristol-Myers Squibb and General Electric Healthcare.
In April 2021, Hualan Biological Bacterin Inc. announced an exclusive agreement with the Russian government to produce 100 million doses of the Sputnik V COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology of Russia’s Ministry of Health.
None of the above seems to have caught the attention of those responsible for US national security.
Clearly, the Department of Defense and US intelligence agencies lack a basic understanding of the direction and scope of China’s biotechnology warfare program.
US government officials seem unaware that COVID-19 was certainly an element of that program, perhaps even a test of it.
This article was originally published in Gateway Pundit on October 22, 2021.
Authors: Lawrence Sellin, Ph.D. / Anna Chen























